Latest Insider Transactions at Rocket Pharmaceuticals, Inc. (RCKT)
This section provides a real-time view of insider transactions for Rocket Pharmaceuticals, Inc. (RCKT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ROCKET PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ROCKET PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 12
2022
|
Martin Wilson General Counsel |
BUY
Other acquisition or disposition
|
Direct |
28,763
+36.58%
|
-
|
|
Aug 12
2022
|
Kinnari Patel |
BUY
Other acquisition or disposition
|
Direct |
52,489
+12.53%
|
-
|
|
Aug 12
2022
|
John Militello |
BUY
Other acquisition or disposition
|
Direct |
14,310
+23.47%
|
-
|
|
Apr 18
2022
|
John Militello |
BUY
Other acquisition or disposition
|
Direct |
7,932
+19.69%
|
-
|
|
Mar 30
2022
|
Jonathan David Schwartz |
SELL
Open market or private sale
|
Direct |
45,000
-10.4%
|
$720,000
$16.25 P/Share
|
|
Feb 14
2022
|
Gaurav Shah CEO |
BUY
Other acquisition or disposition
|
Direct |
23,940
+3.45%
|
-
|
|
Feb 14
2022
|
Kinnari Patel |
BUY
Other acquisition or disposition
|
Direct |
11,970
+3.67%
|
-
|
|
Feb 14
2022
|
John Militello |
BUY
Other acquisition or disposition
|
Direct |
2,903
+10.62%
|
-
|
|
Feb 07
2022
|
Gaurav Shah CEO |
BUY
Open market or private purchase
|
Direct |
22,000
+4.08%
|
$374,000
$17.34 P/Share
|
|
Aug 27
2021
|
Roderick Wong |
BUY
Grant, award, or other acquisition
|
Indirect |
812,516
+4.76%
|
$26,000,512
$32.48 P/Share
|
|
Jul 27
2021
|
Gotham Makker |
SELL
Bona fide gift
|
Indirect |
621,500
-47.94%
|
-
|
|
Jun 17
2021
|
Gotham Makker |
SELL
Open market or private sale
|
Indirect |
400
-0.03%
|
$18,800
$47.12 P/Share
|
|
Jun 16
2021
|
Gotham Makker |
SELL
Open market or private sale
|
Indirect |
34,685
-2.61%
|
$1,595,510
$46.85 P/Share
|
|
May 11
2021
|
Rtw Investments, LP Director |
SELL
Open market or private sale
|
Indirect |
725,000
-4.48%
|
$29,000,000
$40.03 P/Share
|
|
Apr 01
2021
|
Gaurav Shah CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
22,266
-1.45%
|
$1,024,236
$46.29 P/Share
|
|
Mar 31
2021
|
Gaurav Shah CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
94,846
-4.04%
|
$4,268,070
$45.21 P/Share
|
|
Mar 31
2021
|
Gaurav Shah CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
75,880
+11.02%
|
$75,880
$1.69 P/Share
|
|
Mar 30
2021
|
Gaurav Shah CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
85,888
-3.59%
|
$3,693,184
$43.2 P/Share
|
|
Mar 24
2021
|
Rtw Investments, LP Director |
SELL
Other acquisition or disposition
|
Indirect |
1,344,925
-7.67%
|
-
|
|
Mar 24
2021
|
Kinnari Patel |
BUY
Exercise of conversion of derivative security
|
Direct |
93,962
+21.9%
|
$93,962
$1.45 P/Share
|
|
Feb 01
2021
|
Jonathan David Schwartz |
BUY
Exercise of conversion of derivative security
|
Direct |
224,529
+49.35%
|
$224,529
$1.45 P/Share
|
|
Dec 28
2020
|
Kinnari Patel |
SELL
Open market or private sale
|
Direct |
16,761
-7.77%
|
$938,616
$56.84 P/Share
|
|
Dec 10
2020
|
Rtw Investments, LP Director |
BUY
Open market or private purchase
|
Indirect |
247,720
+1.39%
|
$13,872,320
$56.0 P/Share
|
|
Dec 10
2019
|
Rtw Investments, LP Director |
BUY
Open market or private purchase
|
Indirect |
225,000
+1.29%
|
$4,950,000
$22.25 P/Share
|
|
Apr 16
2019
|
Rtw Investments, LP Director |
BUY
Open market or private purchase
|
Indirect |
550,005
+3.12%
|
$9,350,085
$17.5 P/Share
|
|
Dec 28
2018
|
Roderick Wong |
BUY
Grant, award, or other acquisition
|
Indirect |
100,000
+0.6%
|
$1,300,000
$13.93 P/Share
|
|
Nov 27
2018
|
Roderick Wong |
BUY
Grant, award, or other acquisition
|
Indirect |
967,742
+5.57%
|
$14,516,130
$15.5 P/Share
|